Why the study?
To determine whether epicardial adipose tissue amount differs in patients with and without acute COVID-19 infection and myocardial injury.
Does Epicardial Adipose Tissue (EAT) amount differ in patients with and without acute COVID-19 infection and myocardial injury?
Does Epicardial Adipose Tissue (EAT) amount differ in patients with and without acute COVID-19 infection and myocardial injury?
Epicardial adipose tissue thickness measured by echocardiography is associated with acute COVID-19 infection, suggesting a potential interaction between systemic viral inflammation and visceral cardiac fat.
Answers are grounded in this paper and cite their sources.
EAT may mark COVID-19 inflammation; hypothesis-generating and should not yet change practice.
Background: Acute COVID-19 infection frequently affects the cardiovascular system and causes acute myocardial injury. Epicardial Adipose Tissue (EAT), a visceral adipose tissue surrounding the myocardium and coronary arteries, has unique paracrine and endocrine effects, modulating the heart's inflammatory environment. Systemic inflammation stimulates TNF-α and Interleukin-6 secretion from EAT, contributing to cytokine storms and intensifying systemic responses. We aimed to determine whether EAT amount differs in patients with and without acute COVID-19 infection and myocardial injury. Methods: This study analyzed the CoV-COR registry cohort, conducted at the University Hospital Essen, including patients with symptoms suggestive of COVID-19 infection. The infection was confirmed by PCR. EAT thickness was measured by two-dimensional TTE. Conclusion: EAT thickness is associated with the presence of an acute COVID-19 infection but not with a myocardial injury. Further research is needed to assess if systemic viral infection induces dynamic changes in EAT.
No takes yet. Share an insight, caveat, or question.
Küng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: